Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cerberus Therapeutics logo — Modulating immunity with the small—yet, mighty—nanobody

Cerberus Therapeutics

Modulating immunity with the small—yet, mighty—nanobody

Founded 2022 United States Cambridge, United States 7 employees Biotechnology, Health and Wellness +1

General Information

Company Name Cerberus Therapeutics
Founded Year 2022
Location United States Cambridge, United States
Employees 7
Industries Biotechnology, Health and Wellness, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with Cerberus Therapeutics. To contact Cerberus Therapeutics, visit cerberustx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cerberus Therapeutics

Cerberus Therapeutics is a biotechnology startup founded in 2022 in the United States that focuses on utilizing a nanobody-based platform to create novel therapeutics for modulating the immune system. The company's slogan, "Modulating immunity with the small—yet, mighty—nanobody," reflects its core mission. Cerberus Therapeutics recognizes the urgent need for safe and accessible therapies to modulate immune responses, particularly emphasized by the COVID-19 pandemic. The startup has developed innovative strategies to precisely manipulate the immune system in response to debilitating diseases. Its pilot programs primarily target autoimmune disorders and infectious diseases, built on novel biological discoveries originating from the extensive work of its three founders: Dr. Novalia Pishesha, Prof. Hidde Ploegh, and Prof. Harvey Lodish. These individuals bring a wealth of experience and expertise to the company, forming a solid foundation for its research and development efforts. While there is no publicly available information about Cerberus Therapeutics' latest investment or its investors at this time, the potential of its nanobody-based approach in therapeutic development for immune modulation presents an intriguing investment opportunity for venture capitalists seeking to support groundbreaking advancements in biotechnology. Overall, Cerberus Therapeutics has positioned itself as a promising player in the biotechnology industry, with its innovative focus on modulating the immune system sparking interest and potential investment consideration within the startup and investment community.

Taxonomy: Nanobody-based platform, Therapeutics, Modulating immune system, Autoimmune disorders, Infectious diseases, Biotechnology industry, Organic chemistry, Chemical biology, Protein synthesis, Protein modification, Biotech sector, Novel therapeutic leads, Immune response engineering, Disease treatment, Biological discoveries

No funding data available for Cerberus Therapeutics yet.

Cerberus Therapeutics Alternatives & Competitors

View All Alternatives
Cerberus Therapeutics vs
Asylia Therapeutics
Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious diseases.

Series A
1 employees
Biotechnology, Health Care
Cerberus Therapeutics vs
RemedyBio
RemedyBio Ireland

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...

Venture round
7 employees
Biotechnology, Health and Wellness
Cerberus Therapeutics vs
Granza Bio
Granza Bio

Reprogramming Immunity for Target-Specific Medicines

Seed
7 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Cerberus Therapeutics

Modulating immunity with the small—yet, mighty—nanobody
Cerberus Therapeutics was founded in 2022.
Cerberus Therapeutics is headquartered in Cambridge, United States.
Cerberus Therapeutics operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on Nanobody-based platform, Therapeutics, Modulating immune system and Autoimmune disorders.
Cerberus Therapeutics has approximately 7 employees.
Top alternatives and competitors to Cerberus Therapeutics include Asylia Therapeutics, RemedyBio, Granza Bio, Immunaeon, Tentarix Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cerberus Therapeutics and Asylia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cerberus Therapeutics, https://bouncewatch.com/company/cerberus-therapeutics, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes